Literature DB >> 2573392

Cyclic GMP and nitroprusside inhibit the activation of human platelets by fluoroaluminate.

R Deana1, M Ruzzene, M G Doni, F Zoccarato, A Alexandre.   

Abstract

Sodium nitroprusside, an activator of the soluble guanylate cyclase, inhibits the intracellular Ca2+ mobilization, ATP secretion and aggregation of human platelets evoked by fluoroaluminate. Similar results are obtained with 8-bromo-cyclic GMP (8-Br-cGMP). Both nitroprusside and 8-Br-cGMP inhibit the protein kinase C-dependent phosphorylation of the 47 and 20 kDa proteins induced by fluoroaluminate, but not by the protein kinase C activators phorbol ester and diacylglycerol. Since fluoroaluminate interacts directly with a G protein, the present results suggest that the cGMP interferes with platelet activation at the level of G protein-phospholipase C.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573392     DOI: 10.1016/0167-4889(89)90035-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  cGMP inhibits IP3-induced Ca2+ release in intact rat megakaryocytes via cGMP- and cAMP-dependent protein kinases.

Authors:  S Tertyshnikova; X Yan; A Fein
Journal:  J Physiol       Date:  1998-10-01       Impact factor: 5.182

2.  Ca2+ influx in platelets: activation by thrombin and by the depletion of the stores. Effect of cyclic nucleotides.

Authors:  M G Doni; L Cavallini; A Alexandre
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

3.  S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells.

Authors:  R Heller; F Bussolino; R Calvino; D Ghigo; P Alessio; R Todde; R Fruttero; G Pescarmona; A Gasco; U Till
Journal:  Agents Actions       Date:  1993-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.